| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Feb 2025 | 31 Jan 2025 |
| Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter ended December 31 2024. Outcome of the Board Meeting dated February 07, 2025. Financial Results for the quarter ended December 31, 2024. (As per BSE Announcement Dated on 07/02/2025) | ||
| Board Meeting | 12 Nov 2024 | 7 Nov 2024 |
| Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2024 and any other business matters if required with the permission of the Chairman. Appointment of Mr. Ashok Chheda as a Non- Executive Independent Director of the Company. (As Per BSE Announcement Dated on: 12/11/2024) | ||
| Board Meeting | 12 Aug 2024 | 6 Aug 2024 |
| Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Standalone and Consolidated Audited Financial Results for the quarter ended June 30 2024 Outcome of the Board Meeting (As Per Bse Announcement Dated on 12.08.2024) | ||
| Board Meeting | 14 May 2024 | 7 May 2024 |
| Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve Standalone and Consolidated audited Financial Results for the quarter and year ended March 31 2024 and other business matters if required with the permission of the Chairman. Outcome of the Board Meeting Appointment of Mr. Mulesh Manilal Savla as Non- Executive Independent Director of the Company. (As Per BSE Announcement dated on 14.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
